Systems Cell Biology Knowledge Created from High Content Screening
- 1 October 2005
- journal article
- research article
- Published by Mary Ann Liebert Inc in ASSAY and Drug Development Technologies
- Vol. 3 (5) , 501-514
- https://doi.org/10.1089/adt.2005.3.501
Abstract
High content screening (HCS), the large-scale automated analysis of the temporal and spatial changes in cells and cell constituents in arrays of cells, has the potential to create enormous systems cell biology knowledge bases. HCS is being employed along with the continuum of the early drug discovery process, including lead optimization where new knowledge is being used to facilitate the decision-making process. We demonstrate methodology to build new systems cell biology knowledge using a multiplexed HCS assay, designed with the aid of knowledge-mining tools, to measure the phenotypic response of a panel of human tumor cell types to a panel of natural product-derived microtubule-targeted anticancer agents and their synthetic analogs. We show how this new systems cell biology knowledge can be used to design a lead compound optimization strategy for at least two members of the panel, (–)-laulimalide and (+)-discodermolide, that exploits cell killing activity while minimally perturbing the regulation of the cell cycle and the stability of microtubules. Furthermore, this methodology can also be applied to basic biomedical research on cells.Keywords
This publication has 27 references indexed in Scilit:
- Multiplexed high content screening assays create a systems cell biology approach to drug discoveryDrug Discovery Today: Technologies, 2005
- Multidimensional Drug Profiling By Automated MicroscopyScience, 2004
- High-Content Screening with siRNA Optimizes a Cell Biological Approach to Drug Discovery: Defining the Role of P53 Activation in the Cellular Response to Anticancer DrugsSLAS Discovery, 2004
- Complex phenotypic assays in high-throughput screeningCurrent Opinion in Chemical Biology, 2004
- Advances in High Content Screening for Drug DiscoveryASSAY and Drug Development Technologies, 2003
- High-content assays for ligand regulation of G-protein-coupled receptorsDrug Discovery Today, 2003
- Use of proteomic patterns in serum to identify ovarian cancerPublished by Elsevier ,2002
- Advances in molecular labeling, high throughput imaging and machine intelligence portend powerful functional cellular biochemistry toolsJournal of Cellular Biochemistry, 2002
- Cluster analysis and display of genome-wide expression patternsProceedings of the National Academy of Sciences, 1998
- High-Content Screening: A New Approach to Easing Key Bottlenecks in the Drug Discovery ProcessSLAS Discovery, 1997